Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

被引：0
|
作者：
Enrique Grande
Michael C. Kreissl
Sebastiano Filetti
Kate Newbold
Walter Reinisch
Caroline Robert
Martin Schlumberger
Lærke K. Tolstrup
Jose L. Zamorano
Jaume Capdevila
机构：
[1] Hospital Ramón y Cajal,Servicio de Oncología Médica
[2] University Hospital of Wuerzburg,Department of Nuclear Medicine
[3] Central Hospital of Augsburg,Department of Nuclear Medicine
[4] University of Rome “Sapienza”,Department of Internal Medicine and Medical Specialities
[5] Royal Marsden Hospital,Thyroid Unit
[6] Medical University of Vienna,Division of Gastroenterology and Hepatology, Department of Internal Medicine III
[7] University of Paris-Sud,Department of Medical Oncology, Dermatology Unit and INSERM U981, Gustave Roussy Institute
[8] University of Paris-Sud,Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute
[9] Odense University Hospital,Department of Oncology, Clinical Research Unit
[10] Hospital Ramón y Cajal,Cardiology Service
[11] Vall d’Hebron University Hospital,Medical Oncology Department, Gastrointestinal and Endocrine Tumor Unit
[12] Autonomous University of Barcelona,undefined
来源：
Advances in Therapy | 2013年 / 30卷
关键词：
Adverse effects; Antineoplastic agents/adverse effects; Cardiovascular; Dermatology; Medullary thyroid cancer; Medullary thyroid carcinoma; Patient safety; Piperidines/therapeutic use; Protein kinase inhibitors; Thyroid neoplasms/drug therapy; Vandetanib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：945 / 966
页数：21
相关论文
共 50 条
  • [21] Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome
    Pitoia, Fabian
    Bueno, Fernanda
    Schmidt, Angelica
    Lucas, Sabrina
    Cross, Graciela
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (04): : 343 - 346
  • [22] Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response
    Valerio, Laura
    Bottici, Valeria
    Matrone, Antonio
    Piaggi, Paolo
    Viola, David
    Cappagli, Virginia
    Agate, Laura
    Molinaro, Eleonora
    Ciampi, Raffaele
    Tacito, Alessia
    Ramone, Teresa
    Romei, Cristina
    Elisei, Rossella
    ENDOCRINE-RELATED CANCER, 2020, 27 (02) : 97 - 110
  • [23] Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension
    Milling, Rikke Vilsboll
    Grimm, Daniela
    Krueger, Marcus
    Grosse, Jirka
    Kopp, Sascha
    Bauer, Johann
    Infanger, Manfred
    Wehland, Markus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [24] Management of treatment-related toxicities in advanced medullary thyroid cancer
    Tsang, Venessa H. M.
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 236 - 242
  • [25] The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer
    Fallahi, Poupak
    Ferrari, Silvia Martina
    Baldini, Enke
    Biricotti, Marco
    Ulisse, Salvatore
    Materazzi, Gabriele
    Miccoli, Paolo
    Antonelli, Alessandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (11) : 1109 - 1118
  • [26] Meta-Analysis of the Efficacy and Safety Evaluation of Vandetanib in the Treatment of Medullary Thyroid Cancer
    Xian, Tong-cheng
    Yang, Min-ye
    Zhang, Xue-lin
    Wang, Jie
    Luo, Yi
    HORMONE AND METABOLIC RESEARCH, 2024, 56 (09) : 649 - 653
  • [27] Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer
    Nagilla, Madhavi
    Brown, Rebecca L.
    Cohen, Ezra E. W.
    ADVANCES IN THERAPY, 2012, 29 (11) : 925 - 934
  • [28] Efficacy and Safety of Low Dose Vandetanib in Metastatic Medullary Thyroid Cancer
    Modica, R.
    Pizza, G.
    Lo Calzo, F.
    De Cicco, F.
    Sciammarella, C.
    Circelli, L.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2017, 105 : 222 - 222
  • [29] Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis
    Trimboli, Pierpaolo
    Castellana, Marco
    Virili, Camilla
    Giorgino, Francesco
    Giovanella, Luca
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [30] Management of Medullary Thyroid Cancer
    Viola, David
    Elisei, Rossella
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 285 - +
12345